1,402 Shares in UnitedHealth Group Incorporated $UNH Acquired by Versor Investments LP

Key Points

• Versor Investments LP purchased 1,402 shares of UnitedHealth Group, valued around $734,000, indicating institutional interest in the healthcare company.
• Despite some analysts reducing their target prices significantly, the stock has received mixed ratings, with three analysts suggesting a sell and fifteen issuing a buy rating.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, with a total annualized yield of 2.9%, reflecting ongoing returns for shareholders.

Versor Investments LP acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,402 shares of the healthcare conglomerate's stock, valued at approximately $734,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Financial Management Professionals Inc. raised its stake in shares of UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after buying an additional 17 shares in the last quarter. Global Wealth Strategies & Associates raised its stake in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after buying an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after purchasing an additional 21 shares during the last quarter. Retirement Planning Group LLC boosted its position in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after purchasing an additional 21 shares during the period. Finally, Net Worth Advisory Group boosted its position in shares of UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after purchasing an additional 21 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Down 1.5%

Shares of UNH traded down $4.72 during trading hours on Tuesday, hitting $303.77. 22,226,972 shares of the company were exchanged, compared to its average volume of 23,411,996. The company has a market cap of $275.12 billion, a PE ratio of 13.16, a PEG ratio of 1.99 and a beta of 0.43. The firm's 50 day moving average is $289.03 and its 200-day moving average is $393.55. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the company posted $6.80 EPS. The business's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

Analyst Ratings Changes

UNH has been the subject of a number of recent analyst reports. Mizuho decreased their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Bank of America upped their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday. TD Securities reissued a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Robert W. Baird reissued an "underperform" rating and issued a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $367.71.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.